Cookies?
Library Header Image
LSE Research Online LSE Library Services

An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom

Mossialos, Elias ORCID: 0000-0001-8664-9297 and Oliver, Adam ORCID: 0000-0003-3880-9350 (2005) An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom. International Journal of Health Planning and Management, 20 (4). pp. 291-306. ISSN 0749-6753

Full text not available from this repository.
Identification Number: 10.1002/hpm.816

Abstract

The regulation of pharmaceutical markets is an important policy concern in many countries, and is generally undertaken with cost containment, efficiency, quality and equity objectives in mind. This article presents an overview of the demand-side and supply-side regulatory measures that have been introduced in four European countries, namely France, Germany, the Netherlands and the United Kingdom. More specifically, after considering some of the trends in pharmaceutical expenditure in these four countries over recent decades, the article considers the policies that have been introduced to influence patient demand, health care provider behaviour and the pharmaceutical industry. Since many of the policies are concurrently applied, it is difficult to assess the isolated impact of each, particularly because the effect of particular policies may often be country specific. However, it is clear that there is no overriding perfect solution to balancing the cost containment, efficiency, quality and equity objectives in pharmaceutical policy. No one policy or policy combination is right for all countries, and different countries will need to meet their own objectives through policy approaches that reflect their own particular environment.

Item Type: Article
Official URL: http://www3.interscience.wiley.com/journal/4005/ho...
Additional Information: (c) 2005 John Wiley & Sons, Ltd.
Divisions: Social Policy
LSE Health
Subjects: H Social Sciences > H Social Sciences (General)
R Medicine > RA Public aspects of medicine
Date Deposited: 21 Jul 2008 08:23
Last Modified: 11 Dec 2024 22:53
URI: http://eprints.lse.ac.uk/id/eprint/19664

Actions (login required)

View Item View Item